Back to search

University of Alabama Birmingham

Translocation of Shed Syndecan-1 to the Nucleus: A Novel Mechanism of Tumor-Host Crosstalk

Abstract

dc:description.abstract

Multiple myeloma is a hematological malignancy of plasma cells that disseminates throughout the body. Crosstalk between myeloma and host cells is critical to the establishment of a microenvironment conducive to tumor growth and progression. An important mediator of this crosstalk is syndecan-1, a heparan sulfate proteoglycan. Syndecan-1 is proteolytically shed from the surface of myeloma cells and is abundant in the bone marrow microenvironment and serum of myeloma patients. Shed syndecan-1 facilitates tumor-host crosstalk within the microenvironment to drive tumor growth, angiogenesis, and metastasis. We now report for the first time that shed syndecan-1 can be taken up by a recipient cell and transported to the nucleus. This was discovered by incubating bone marrow-derived stromal cells with medium conditioned by myeloma cells producing high levels of shed syndecan-1. Importantly, shed syndecan-1 is detected in the nucleus as early as 15 minutes after addition of medium containing shed syndecan-1 to cells. Translocation of shed syndecan-1 to the nucleus of the stromal cells required the sulfated heparan sulfate chains of syndecan-1 and addition of heparin or heparan sulfate blocked shed syndecan-1 transport to the nucleus. Interestingly, cargo such as hepatocyte growth factor (HGF) bound to shed syndecan-1 heparan sulfate chains was transported to the nucleus along with shed syndecan-1 and removal of heparan sulfate-bound cargo from shed syndecan-1 abolished its translocation to the nucleus of stromal cells. Once in the nucleus, shed syndecan-1 reduced histone acetyltransferase (HAT) activity and interacted directly with the HAT enzyme p300. Overall these results reveal a novel mechanism of tumor-host crosstalk whereby tumor-derived shed syndecan-1 disrupts nuclear functions in stromal cells which may lead to altered gene expression and abnormal cell behavior. Therapeutic regulation of syndecan-1 shedding, its binding to the cell surface or translocation to the nucleus represent novel strategies to control the progression of myeloma and other cancers.

Degree

thesis:*
Level thesis:degree_level
Dissertation

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Stewart, Mark
Contributors dc:contributor
  • Ralph Sanderson
  • James Collawn
  • Douglas Hurst
  • Christopher Klug
  • Elizabeth Sztul

Subjects

dc:subject × 6

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Alabama Birmingham
Base URL
digitalcommons.library.uab.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Stewart, Mark. Translocation of Shed Syndecan-1 to the Nucleus: A Novel Mechanism of Tumor-Host Crosstalk. Dissertation thesis, https://digitalcommons.library.uab.edu/etd-collection/3045